持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/09/28 | 9,620 | 9,700 | 9,370 | 9,390 | -270 | -2.8% | 51,900 |
| 2018/09/27 | 9,500 | 9,690 | 9,450 | 9,660 | +170 | +1.8% | 46,300 |
| 2018/09/26 | 9,420 | 9,590 | 9,330 | 9,490 | -10 | -0.1% | 60,800 |
| 2018/09/25 | 8,940 | 9,500 | 8,940 | 9,500 | +650 | +7.3% | 84,900 |
| 2018/09/21 | 8,860 | 8,930 | 8,810 | 8,850 | +70 | +0.8% | 28,300 |
| 2018/09/20 | 8,900 | 8,910 | 8,760 | 8,780 | -70 | -0.8% | 19,400 |
| 2018/09/19 | 8,750 | 8,890 | 8,690 | 8,850 | +130 | +1.5% | 30,300 |
| 2018/09/18 | 8,500 | 8,720 | 8,380 | 8,720 | +300 | +3.6% | 48,200 |
| 2018/09/14 | 8,420 | 8,510 | 8,390 | 8,420 | -40 | -0.5% | 41,500 |
| 2018/09/13 | 8,340 | 8,500 | 8,340 | 8,460 | +160 | +1.9% | 28,000 |
| 2018/09/12 | 8,510 | 8,510 | 8,230 | 8,300 | -200 | -2.4% | 27,300 |
| 2018/09/11 | 8,510 | 8,520 | 8,440 | 8,500 | +40 | +0.5% | 26,800 |
| 2018/09/10 | 8,550 | 8,560 | 8,440 | 8,460 | -70 | -0.8% | 18,500 |
| 2018/09/07 | 8,440 | 8,560 | 8,430 | 8,530 | +30 | +0.4% | 15,300 |
| 2018/09/06 | 8,490 | 8,510 | 8,430 | 8,500 | -30 | -0.4% | 10,600 |
| 2018/09/05 | 8,540 | 8,580 | 8,480 | 8,530 | -50 | -0.6% | 15,600 |
| 2018/09/04 | 8,590 | 8,600 | 8,480 | 8,580 | -10 | -0.1% | 10,400 |
| 2018/09/03 | 8,680 | 8,690 | 8,550 | 8,590 | ±0 | ±0% | 17,200 |
| 2018/08/31 | 8,430 | 8,640 | 8,430 | 8,590 | +80 | +0.9% | 20,000 |
| 2018/08/30 | 8,500 | 8,550 | 8,480 | 8,510 | +20 | +0.2% | 19,300 |
| 2018/08/29 | 8,310 | 8,490 | 8,270 | 8,490 | +280 | +3.4% | 22,300 |
| 2018/08/28 | 8,430 | 8,430 | 8,090 | 8,210 | -100 | -1.2% | 34,400 |
| 2018/08/27 | 8,370 | 8,370 | 8,240 | 8,310 | +10 | +0.1% | 10,900 |
| 2018/08/24 | 8,270 | 8,340 | 8,270 | 8,300 | +30 | +0.4% | 6,900 |
| 2018/08/23 | 8,200 | 8,300 | 8,200 | 8,270 | +30 | +0.4% | 12,000 |
| 2018/08/22 | 8,050 | 8,290 | 8,040 | 8,240 | +110 | +1.4% | 13,800 |
| 2018/08/21 | 8,160 | 8,170 | 8,100 | 8,130 | ±0 | ±0% | 7,000 |
| 2018/08/20 | 8,150 | 8,230 | 8,080 | 8,130 | -110 | -1.3% | 10,700 |
| 2018/08/17 | 8,260 | 8,300 | 8,180 | 8,240 | -20 | -0.2% | 10,000 |
| 2018/08/16 | 8,350 | 8,350 | 8,200 | 8,260 | -170 | -2% | 18,800 |
| 2018/08/15 | 8,540 | 8,540 | 8,390 | 8,430 | -60 | -0.7% | 13,000 |
| 2018/08/14 | 8,340 | 8,500 | 8,340 | 8,490 | +200 | +2.4% | 17,400 |
| 2018/08/13 | 8,370 | 8,410 | 8,280 | 8,290 | -230 | -2.7% | 18,600 |
| 2018/08/10 | 8,610 | 8,620 | 8,510 | 8,520 | -110 | -1.3% | 21,700 |
| 2018/08/09 | 8,330 | 8,750 | 8,260 | 8,630 | +310 | +3.7% | 45,200 |
| 2018/08/08 | 8,400 | 8,430 | 8,300 | 8,320 | -110 | -1.3% | 13,000 |
| 2018/08/07 | 8,390 | 8,430 | 8,290 | 8,430 | ±0 | ±0% | 16,400 |
| 2018/08/06 | 8,320 | 8,560 | 8,320 | 8,430 | +130 | +1.6% | 36,800 |
| 2018/08/03 | 7,840 | 8,300 | 7,840 | 8,300 | +310 | +3.9% | 48,300 |
| 2018/08/02 | 8,240 | 8,240 | 7,980 | 7,990 | -250 | -3% | 17,900 |
| 2018/08/01 | 8,300 | 8,320 | 8,180 | 8,240 | +150 | +1.9% | 31,800 |
| 2018/07/31 | 8,260 | 8,260 | 8,030 | 8,090 | -160 | -1.9% | 21,200 |
| 2018/07/30 | 8,350 | 8,350 | 8,230 | 8,250 | -150 | -1.8% | 12,200 |
| 2018/07/27 | 8,280 | 8,430 | 8,240 | 8,400 | +110 | +1.3% | 20,300 |
| 2018/07/26 | 8,150 | 8,290 | 8,080 | 8,290 | +230 | +2.9% | 20,300 |
| 2018/07/25 | 8,070 | 8,080 | 8,010 | 8,060 | -10 | -0.1% | 6,400 |
| 2018/07/24 | 8,180 | 8,180 | 8,040 | 8,070 | -20 | -0.2% | 9,800 |
| 2018/07/23 | 8,020 | 8,160 | 8,020 | 8,090 | +30 | +0.4% | 8,000 |
| 2018/07/20 | 8,060 | 8,170 | 8,040 | 8,060 | -60 | -0.7% | 12,900 |
| 2018/07/19 | 8,190 | 8,190 | 8,060 | 8,120 | -10 | -0.1% | 9,100 |
1501～
1550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
